Lotensin - NDC Database

16 records found
Page:1
0078-0447 image
0078-0447 May 31, 2012
Lotensin 5 mg Oral Tablet by Novartis Pharmaceuticals Corporation
0078-0448 image
0078-0448 May 31, 2012
Lotensin 10 mg Oral Tablet by Novartis Pharmaceuticals Corporation
0078-0449 image
0078-0449 Jun 25, 1991
Lotensin 20 mg Oral Tablet by Novartis Pharmaceuticals Corporation
0078-0450 image
0078-0450 Jun 25, 1991
Lotensin 40 mg Oral Tablet by Novartis Pharmaceuticals Corporation
30698-447 image
30698-447 Jun 21, 1991
Lotensin 5 mg Oral Tablet by Validus Pharmaceuticals LLC
30698-448 image
30698-448 Jun 21, 1991
Lotensin 10 mg Oral Tablet by Validus Pharmaceuticals LLC
30698-449 image
30698-449 Jun 25, 1991
Lotensin 20 mg Oral Tablet by Validus Pharmaceuticals LLC
30698-450 image
30698-450 Jun 25, 1991
Lotensin 40 mg Oral Tablet by Validus Pharmaceuticals LLC
54868-2350 image
54868-2350 Nov 04, 2003
Lotensin 10 mg Oral Tablet by Physicians Total Care, Inc.
54868-2351 image
54868-2351 Mar 23, 1994
Lotensin 20 mg Oral Tablet by Physicians Total Care, Inc.
54868-2352 image
54868-2352 Feb 24, 1999
Lotensin 40 mg Oral Tablet by Physicians Total Care, Inc.
54868-3690 image
54868-3690 Dec 30, 1996
Lotensin 5 mg Oral Tablet by Physicians Total Care, Inc.
55289-086 image
55289-086 Jun 25, 1991
Lotensin 20 mg Oral Tablet by Pd-rx Pharmaceuticals, Inc.
30698-452 May 30, 1992
Lotensin Hct 10/12.5 Oral Tablet by Validus Pharmaceuticals LLC
30698-453 May 30, 1992
Lotensin Hct (Benazepril Hcl 20 mg / Hctz 12.5 mg) Oral Tablet by Validus Pharmaceuticals LLC
30698-454 May 30, 1992
Lotensin Hct 20/25 Oral Tablet by Validus Pharmaceuticals LLC
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.